powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1043637192
Fadwa Sumrein
D.O
Endocrinology
Clifton,
NJ
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CCN 310006
Hospital
CCN 310019
Hospital
CCN 310045
Hospital
QUALITY · MIPS · 2024
Final MIPS score
96.1
Quality
86.9
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.89%
APM Entity
PRESCRIBING · PART D · 2024
Total Rx claims
7,378
Beneficiaries
—
Total drug cost
$3.8M
Distinct drugs
43
Brand share
70.7%
Top prescribed drugs
Semaglutide
834 claims
Metformin Hcl
679 claims
Empagliflozin
601 claims
Insulin Glargine,hum.Rec.Anlog
505 claims
Levothyroxine Sodium
474 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
850
Unique beneficiaries
—
Total services
1,697
Distinct HCPCS
8
Medicare payment
$99K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 290 Endocrinology providers in NJ — above median (cohort median 1,480).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
65
By payment type
Food and Beverage
$2K
Travel and Lodging
$605
Top paying entities
Food and Beverage
$2K
Travel and Lodging
$605
